tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Debjit Chattopadhyay, 167 are a BUY (90.76%), 17 are a HOLD (9.24%).
Analyst Debjit Chattopadhyay, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 49.52% that have a potential upside of 38.47% achieved within 318 days.
Debjit Chattopadhyay’s has documented 382 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QURE, Uniqure NV at 25-Sep-2025.
Analyst best performing recommendations are on HARP (HARPOON THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $22 was fulfilled within 1 day with a profit of $3.15 (12.52%) receiving and performance score of 125.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$60
$5.08 (9.25%)
$30
12 days ago
(25-Sep-2025)
5/6 (83.33%)
$7.35 (13.96%)
143
Buy
$80
$25.08 (45.67%)
$58
12 days ago
(25-Sep-2025)
3/5 (60%)
$27.35 (51.95%)
350
Hold
$56
$1.08 (1.97%)
$20
12 days ago
(25-Sep-2025)
6/7 (85.71%)
$3.35 (6.36%)
272
Buy
$95
$40.08 (72.98%)
$28
12 days ago
(25-Sep-2025)
10/13 (76.92%)
$42.35 (80.44%)
872
Buy
$68
$13.08 (23.82%)
$56
13 days ago
(24-Sep-2025)
2/4 (50%)
$20.5 (43.16%)
730
Which stock is Debjit Chattopadhyay is most bullish on?
Which stock is Debjit Chattopadhyay is most reserved on?
What Year was the first public recommendation made by Debjit Chattopadhyay?
